Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy

40Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study assessed the pharmacokinetics and dosing adequacy of piperacillin in febrile neutropenic patients after the first dose. Pharmacokinetic analysis was performed using noncompartmental methods. We observed an elevated volume of distribution (29.7±8.0 liters [mean±standard deviation]) and clearance (20.2±7.5 liters/h) compared to data from other patient populations. Antibiotic exposure did not consistently result in therapeutic targets. We conclude that alternative dosing strategies guided by therapeutic drug monitoring may be required to optimize exposure. © 2014, American Society for Microbiology.

Cite

CITATION STYLE

APA

Sime, F. B., Roberts, M. S., Warner, M. S., Hahn, U., Robertson, T. A., Yeend, S., … Roberts, J. A. (2014). Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy. Antimicrobial Agents and Chemotherapy, 58(6), 3533–3537. https://doi.org/10.1128/AAC.02340-14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free